COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,627 Articles (22,913 medRxiv, 8,714 bioRxiv)

Most recent first Previous |  Page 855: Articles 8541-8550  | Next

Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina
Gonzalez, S. E., Olszevicki, S., Gaiano, A., Varela Baino, A. N., Regairaz, L., Salazar, M., Pesci, S., Marin, L., Gonzalez, V., Varela, T., Ceriani, L., Garcia, E., Kreplak, N., Navarro, A., Estenssoro, E., Marsico, F. L.
10.1101/2022.04.18.22273978 — Posted: 2022-04-19
Predictors of COVID-19 vaccine uptake: An online longitudinal study of US Veterans and non-Veterans
Thorpe, A., Fagerlin, A., Drews, F. A., Shoemaker, H., Brecha, F. S., Scherer, L. D.
10.1101/2022.04.19.22273818 — Posted: 2022-04-19
A retrospective cross-sectional analysis of community perceptions of flu and COVID-19 vaccines at Turtle Creek Primary Care Center
Murali, A., Sojati, J., Pressimone, C., Levochkina, M., Griffith, K., Fan, E., Dakroub, A.
10.1101/2022.04.15.22273479 — Posted: 2022-04-19
Coding Long COVID: Characterizing a new disease through an ICD-10 lens
Pfaff, E., Madlock-Brown, C., Baratta, J. M., Bhatia, A., Davis, H., Girvin, A. T., Hill, E., Kelly, L., Kostka, K., Loomba, J., McMurry, J., Wong, R., Bennett, T. D., Moffitt, R., Chute, C. G., Haendel, M., The N3C Consortium, , The RECOVER Consortium
10.1101/2022.04.18.22273968 — Posted: 2022-04-19
Methadone overdoses increased 48% during the COVID-19 epidemic
Kaufman, D. E., Kennalley, A. L., McCall, K. L., Piper, B. J.
10.1101/2022.04.14.22273870 — Posted: 2022-04-19
Estimating the risk of hospitalisation and death in England's remaining unvaccinated population
Shingleton, J., Dyke, S., Walker, B. F., Herrick, A., Finnie, T.
10.1101/2022.04.13.22272869 — Posted: 2022-04-19
SARS-CoV-2 evolution and immune escape in immunocompromised patients treated with exogenous antibodies
Scherer, E., Babiker, A., Adelman, M. W., Allman, B., Key, A., Kleinhenz, J. M., Langsjoen, R. M., Nguyen, P.-V., Onyechi, I., Sherman, J. D., Simon, T. W., Soloff, H., Tarabay, J., Varkey, J., Webster, A. S., Weiskopf, D., Weissman, D. B., Xu, Y., Waggoner, J. J., Koelle, K., Rouphael, N., Pouch, S. M., Piantadosi, A.
10.1101/2022.04.12.22273675 — Posted: 2022-04-19
Modeling COVID-19 disease biology to identify drug treatment candidates
Jessen, W. J., Gaisenband, S. D., Quintanilla, M., Lula, S., McLeroth, P., Sullivan, A., Letovsky, S.
10.1101/2022.04.18.488660 — Posted: 2022-04-18
Effectiveness and waning of protection with different SARS-CoV-2 primary and booster vaccines during the Delta pandemic wave in 2021 in Hungary (HUN-VE 3 study)
Voko, Z., Kiss, Z., Surjan, G., Surjan, O., Barcza, Z., Wittmann, I., Molnar, G. A., Nagy, D., Muller, V., Bogos, K., Nagy, P., Kenessey, I., Weber, A., Polivka, L., Palosi, M., Szlavik, J., Rokszin, G., Muller, C., Szekanecz, Z., Kasler, M.
10.1101/2022.04.14.22273898 — Posted: 2022-04-18
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses
Tauzin, A., Gong, S. Y., Painter, M. M., Goel, R. R., Chatterjee, D., Beaudoin-Bussieres, G., Marchitto, L., Boutin, M., Laumaea, A., Okeny, J., Gendron-Lepage, G., Bourassa, C., Medjahed, H., Goyette, G., Williams, J. C., Bo, Y., Gokool, L., Morrisseau, C., Arlotto, P., Bazin, R., Fafard, J., Tremblay, C., Kaufmann, D. E., De Serres, G., Cote, M., Duerr, R., Martel-Laferriere, V., Greenplate, A. R., Wherry, E. J., Finzi, A.
10.1101/2022.04.18.22273967 — Posted: 2022-04-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).